Welcome to the last installment in our video series highlighting the ways Cystic Fibrosis Foundation Therapeutics (CFFT) and industry are tackling cystic fibrosis from every angle. This week's topic explores new approaches to fighting infections that are in CFFT's drug development pipeline.
Watch the video below to hear Dr. Jennifer Taylor-Cousar describe why lung infections are a common problem for people with CF and what is being done to address the different types of infections that are problematic for people with CF.
If you haven't already, check out the previous posts on restoring CFTR function, reducing inflammation and restoring liquid to airway surfaces in the lungs.
To learn more about drugs that are in development, visit our drug development pipeline. Or if you would like to search for a clinical trial, visit the clinical trial search tool.